High prevalence of acquired von Willebrand's syndrome in patients with thyroid diseases undergoing thyroid surgery.

BACKGROUND AND OBJECTIVES Various coagulation abnormalities occur in patients with thyroid diseases. These abnormalities range from subclinical laboratory findings to hemorrhage or thromboembolism. However, the prevalence of hemostatic abnormalities in patients with thyroid diseases is still unclear. DESIGN AND METHODS Between January 1999 and December 2003, 1342 consecutive patients with various thyroid diseases who were candidates for thyroid surgery underwent preoperative screening of hemostatic parameters including prothrombin time, activated partial thromboplastin time and platelet-related hemostasis with the PFA-100 platelet-function analyzer. RESULTS Thirty-nine patients (2.9%) had abnormalities of the coagulation screening tests. Of these, 35 patients had von Willebrand's disease (type 1 in 33 cases and type 2A in 2 cases), 2 patients had decreased platelet aggregability, and 2 patients had coagulation factor XI deficiency. As all patients with coagulation abnormalities responded to subcutaneous desmopressin injection (0.3 microg/Kg BW), this drug was successfully used as surgical prophylaxis. INTERPRETATION AND CONCLUSIONS Up to 3% of patients with thyroid diseases undergoing thyroid surgery have coagulation abnormalities, in most cases resembling von Willebrand's disease. Coagulation screening tests are needed in order to identify those patients at increased risk of bleeding.

[1]  P. Parrilla,et al.  Prospective Study of Postoperative Complications After Total Thyroidectomy for Multinodular Goiters by Surgeons With Experience in Endocrine Surgery , 2004, Annals of surgery.

[2]  C. Erem,et al.  BLOOD COAGULATION AND FIBRINOLYTIC ACTIVITY IN HYPOTHYROIDISM , 2003, International journal of clinical practice.

[3]  C. Lombardi,et al.  Total thyroidectomy for management of benign thyroid disease: Review of 526 cases , 2002, World Journal of Surgery.

[4]  P. Mannucci,et al.  Guidelines for the diagnosis and management of von Willebrand disease in Italy , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[5]  C. Erem,et al.  Blood coagulation and fibrinolysis in patients with hyperthyroidism , 2002, Journal of endocrinological investigation.

[6]  G. Lippi,et al.  Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing thyroid surgery , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[7]  J. Michiels,et al.  Acquired von Willebrand Syndrome Type 1 in Hypothyroidism: Reversal After Treatment With Thyroxine , 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[8]  G. Lippi,et al.  Prophylactic use of desmopressin in surgery of six patients with symptomatic heterozygous factor XI deficiency. , 2000, Haematologica.

[9]  P. Giral,et al.  Relationship between thyroid hormones and fibrinogen levels. , 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[10]  Lee,et al.  Acquired von Willebrand syndrome – report of 10 cases and review of the literature , 1999, Haemophilia : the official journal of the World Federation of Hemophilia.

[11]  T. Hashimoto,et al.  Increased Plasma Levels of Free Tissue Factor Pathway Inhibitor in Patients with Graves’ Disease , 1998, Thrombosis and Haemostasis.

[12]  H. Rinder,et al.  Acquired von Willebrand's disease: A concise review , 1997, American journal of hematology.

[13]  L. Hofbauer,et al.  Coagulation disorders in thyroid diseases. , 1997, European journal of endocrinology.

[14]  L. Hofbauer,et al.  Graves' disease associated with the primary antiphospholipid syndrome. , 1996, The Journal of rheumatology.

[15]  F. Rodeghiero,et al.  Clinical usefulness of desmopressin for prevention of surgical bleeding in patients with symptomatic heterozygous factor XI deficiency , 1996, British journal of haematology.

[16]  P. De Feo.  Hormonal regulation of human protein metabolism. , 1996, European journal of endocrinology.

[17]  R. Smallridge,et al.  Acquired von willebrand's disease: A rare manifestation of postpartum thyroiditis , 1995, American journal of hematology.

[18]  S. Lichtman,et al.  Acquired von Willebrand's syndrome causing a hemorrhagic diathesis in a patient with hypothyroidism. , 1995, Thyroid : official journal of the American Thyroid Association.

[19]  B. Myrup,et al.  Primary haemostasis in thyroid disease , 1995, Journal of internal medicine.

[20]  C. Bruggers,et al.  Acquired von Willebrand disease in twins with autoimmune hypothyroidism: response to desmopressin and L-thyroxine therapy. , 1994, The Journal of pediatrics.

[21]  V. Tjan-Heijnen,et al.  A patient with postpartum primary hypothyroidism and acquired von Willebrand's disease. , 1994, The Netherlands journal of medicine.

[22]  X. Wang,et al.  Elevated plasma levels of VWF:Ag in hyperthyroidism are mediated through beta-adrenergic receptors. , 1993, Endocrine research.

[23]  E. Martino,et al.  Activation of blood coagulation and fibrinolysis in Graves' disease. , 1991, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[24]  H. Hambley,et al.  Acquired von Willebrand's disease and hypothyroidism: report of a case presenting with menorrhagia. , 1990, Postgraduate medical journal.

[25]  H. Ford,et al.  Haemostasis in hypothyroidism. , 1990, Postgraduate medical journal.

[26]  C. Legnani,et al.  Association of Reduced Factor VIII with Impaired Platelet Reactivity to Adrenalin and Collagen after Total Thyroidectomy , 1989, Thrombosis and Haemostasis.

[27]  E. Martino,et al.  Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment , 1988, Journal of endocrinological investigation.

[28]  P. Maccallum,et al.  HYPOTHYROIDISM AND VON WILLEBRAND'S DISEASE , 1987, The Lancet.

[29]  M. Greaves,et al.  HYPOTHYROIDISM AS A CAUSE OF ACQUIRED VON WDLLEBRAND'S DISEASE , 1987, The Lancet.

[30]  I. Rosen,et al.  The factor of factor XI deficiency in thyroid neoplasia. , 1986, Surgery.

[31]  A. Vagnucci,et al.  Hemostatic defects in response to aspirin challenge in hypothyroidism , 1986, American journal of hematology.

[32]  J. Rogers,et al.  Factor VIII activity in normal volunteers receiving oral thyroid hormone. , 1983, The Journal of laboratory and clinical medicine.

[33]  J. Rogers,et al.  Factor VIII activity and thyroid function. , 1982, Annals of internal medicine.

[34]  A. van Oosterom,et al.  Metabolism of the Coagulation Factors of the Prothrombin Complex in Hypothyroidism in Man , 1979, Thrombosis and Haemostasis.

[35]  P. D. Bewsher,et al.  Coagulation and fibrinolysis in thyroid disease. , 1978, Acta haematologica.

[36]  H. Vik-mo,et al.  Haemostatic and lipid abnormalities in hypothyroidism. , 2009, Scandinavian journal of haematology.

[37]  N. Farid,et al.  Blood Coagulation and Fibrinolysis in Thyroid Disease , 1976, Thrombosis and Haemostasis.

[38]  A. Hellem,et al.  The adhesiveness of human blood platelets and thyroid function. , 2009, Acta medica Scandinavica.

[39]  R. Doe,et al.  Low platelet adhesiveness and other hemostatic abnormalities in hypothyroidism. , 1975, Annals of internal medicine.

[40]  C. Abildgaard,et al.  Blood coagulation in thyroid dysfunction. , 1965, The New England journal of medicine.

[41]  P. Vuopio.  Red cell enzymes in anemia. , 1963, Scandinavian journal of clinical and laboratory investigation.